Wells Fargo & Company Night Hawk Biosciences, Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.15 - $0.45 $0 - $1	3 Added 1.57%	194 $0
Q4 2023 Feb 09, 2024	BUY	$0.26 - $0.51 $2 - $5	10 Added 5.52%	191 $0
Q3 2023 Nov 13, 2023	BUY	$0.5 - $0.72 $1 - $2	3 Added 1.69%	181 $0
Q2 2023 Aug 15, 2023	BUY	$0.62 - $0.87 $5 - $7	9 Added 5.33%	178 $0
Q1 2023 May 12, 2023	BUY	$0.83 - $1.24 $2 - $3	3 Added 1.81%	169 $0
Q4 2022 Feb 13, 2023	BUY	$0.77 - $1.62 $3 - $6	4 Added 2.47%	166 $0
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $17 - $29	-10 Reduced 5.81%	162 $0
Q2 2022 Aug 12, 2022	BUY	$1.65 - $3.13 $26 - $50	16 Added 10.26%	172 $0
Q3 2021 Nov 15, 2021	SELL	$5.9 - $7.44 $35 - $44	-6 Reduced 3.7%	156 $1,000
Q2 2021 Aug 16, 2021	BUY	$5.78 - $9.6 $80 - $134	14 Added 9.46%	162 $1,000
Q1 2021 May 13, 2021	SELL	$5.67 - $12.54 $163,596 - $361,816	-28,853 Reduced 99.49%	148 $1,000
Q4 2020 Feb 09, 2021	BUY	$5.28 - $9.59 $153,125 - $278,119	29,001 New	29,001 $155,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.